Veklury

Land: New Zealand

Språk: engelsk

Kilde: Medsafe (Medicines Safety Authority)

Aktiv ingrediens:

Remdesivir 100mg (approx 5% overfill);  

Tilgjengelig fra:

Gilead Sciences (NZ)

Dosering :

100 mg

Legemiddelform:

Powder for injection

Sammensetning:

Active: Remdesivir 100mg (approx 5% overfill)   Excipient: Betadex Hydrochloric acid Sodium hydroxide

Resept typen:

Prescription

Indikasjoner:

Veklury is indicated for the treatment of coronavirus disease 2019 (COVID-19) in: - adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) who have pneumonia due to SARS-CoV-2, and who require supplemental oxygen. - adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at high risk of progressing to severe COVID-19.

Produkt oppsummering:

Package - Contents - Shelf Life: Vial, glass, Type I clear, an elastomeric closure, and an aluminium overseal with a flip-off cap - 1 dose units - 36 months from date of manufacture stored at or below 30°C 4 hours reconstituted stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)

Autorisasjon dato:

2021-10-14